PTC Industries shares climbed more than 4% on Friday after the company announced a defence order worth over ₹100 crore from ...

The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' oral medication for a rare genetic disorder ...

The American Chamber of Commerce in Korea announced Tuesday that it signed a memorandum of understanding with US software ...

PTC Industries Ltd announced the appointment of Baljinder Singh (Bal) Koura as Vice President - Operations, Aerospace ...

The small molecule, vatiquinone, had already flunked a Phase III trial, but the company pushed ahead with an approval bid ...

PTC Therapeutics has long been trying to workshop its vatiquinone into a marketable treatment for Friedreich's ataxia (FA) ...

Sachin Agarwal, CMD of PTC Industries, sees global defence demand driving growth, backed by a ₹700 crore order book, 25% ...

This was the stock's fifth consecutive day of gains.

This was the stock's second consecutive day of losses.

The U.S. Food and Drug Administration has declined to approve PTC Therapeutics' drug to treat a rare genetic disorder with ...